DPX 102
Alternative Names: DPX-102Latest Information Update: 15 Jan 2025
Price :
$50 *
At a glance
- Originator Damona Pharmaceuticals
- Class Antiepileptic drugs; Anxiolytics; Small molecules
- Mechanism of Action GABA A alpha 2 receptor modulators; GABA A alpha 3 receptor modulators; GABA A alpha 5 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Anxiety disorders; Epilepsy
Most Recent Events
- 18 Dec 2024 Early research in Anxiety disorders in Canada (unspecified route) prior to December 2024 (Damona Pharmaceuticals pipeline, December 2024)
- 18 Dec 2024 Early research in Epilepsy in Canada (unspecified route) prior to December 2024 (Damona Pharmaceuticals pipeline, December 2024)